Christopher Cleary's most recent trade in Orchestra BioMed Holdings Inc was a trade of 42,553 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 42,553 | 42,553 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 23 Jun 2026 | 3,510 | 33,391 | - | 0 | Common Stock, par value $0.0001 per share | |
| Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 05 Feb 2026 | 676 | 36,901 | - | 3.7 | 2,508 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 15,000 | 37,577 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 36,797 | 36,797 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 12,422 | 22,577 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 30,742 | 30,742 | - | - | Stock Option (Right to Buy) | |
| Orchestra BioMed Holdings Inc | Christopher Cleary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 10,155 | 10,155 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") |